ArticleActa neuropathologica communications2022

Soluble CD146, a biomarker and a target for preventing resistance to anti-angiogenic therapy in glioblastoma.

Ahmad Joshkon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.